|
"The overall decrease in revenue was primarily attributable to the delay of $2.9 million of distributor orders which were expected to be shipped in September, but due to logistical constraints were not completed until early October; these delayed shipments will have a meaningfully positive impact on Correvio's fourth quarter 2019 financial results. " |
|
| aus der Diskussion: | CORV (Mkap $95 M) FDA Entscheidung in Dezember /ADCOM eventuell in November |
| Autor (Datum des Eintrages): | techxxnine (14.11.19 15:44:03) |
| Beitrag: | 14 von 212 (ID:61923155) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |